Clinical Trials Directory

Trials / Completed

CompletedNCT04612192

Light Therapy for Chronic Insomnia in General Practice

Light Therapy for Chronic Insomnia in General Practice: a Randomized Double Blind Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
240 (actual)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

* Sleep disorders, especially insomnia * Attention deficits (or disorders), daytime somnolence and drug dependence * The goal is to evaluate whether light therapy could be used as an efficient alternative treatment with direct application in general practice

Detailed description

Insomnia affects 15 to 20% of the general French adult population and increases with age. General practitioners (GPs) are the first confronted to sleep disorders, especially insomnia. Cognitive-behavioral therapies (CBT) have proven effective, but their implementation in everyday practice is limited, and alternative treatments are still needed. Light not only has a great influence on the sleep-wake cycle and alertness, but also on mood and cognitive functions. The administration time of light condition will be calculated for each individual in a modality that has no impact on the circadian phase. Study will be conduct on an outpatient basis in general practice

Conditions

Interventions

TypeNameDescription
DEVICEActive luminettereceive an active light using glasses of 1500 lux (an average of 180 photons/s/cm2, with a maximum wavelenght at 468 nm), 30-minute long light therapy in the morning, in a time period defined by sleep log and chronotype questionnaire, on a 4-week period
DEVICEPlacebo luminettereceive a placebo light using glasses (an average of n photons/s/cm2, single- band spectrum with a narrow peak at 660 nm under 50 lux), with the same modality as the experimental group

Timeline

Start date
2021-04-13
Primary completion
2025-02-12
Completion
2025-02-12
First posted
2020-11-02
Last updated
2025-03-12

Locations

3 sites across 1 country: France

Source: ClinicalTrials.gov record NCT04612192. Inclusion in this directory is not an endorsement.